Cargando…
Transcutaneous vaccination via laser microporation
Driven by constantly increasing knowledge about skin immunology, vaccine delivery via the cutaneous route has recently gained renewed interest. Considering its richness in immunocompetent cells, targeting antigens to the skin is considered to be more effective than intramuscular or subcutaneous inje...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462999/ https://www.ncbi.nlm.nih.gov/pubmed/22750193 http://dx.doi.org/10.1016/j.jconrel.2012.06.031 |
_version_ | 1782245237654028288 |
---|---|
author | Weiss, Richard Hessenberger, Michael Kitzmüller, Sophie Bach, Doris Weinberger, Esther E. Krautgartner, Wolf D. Hauser-Kronberger, Cornelia Malissen, Bernard Boehler, Christof Kalia, Yogeshvar N. Thalhamer, Josef Scheiblhofer, Sandra |
author_facet | Weiss, Richard Hessenberger, Michael Kitzmüller, Sophie Bach, Doris Weinberger, Esther E. Krautgartner, Wolf D. Hauser-Kronberger, Cornelia Malissen, Bernard Boehler, Christof Kalia, Yogeshvar N. Thalhamer, Josef Scheiblhofer, Sandra |
author_sort | Weiss, Richard |
collection | PubMed |
description | Driven by constantly increasing knowledge about skin immunology, vaccine delivery via the cutaneous route has recently gained renewed interest. Considering its richness in immunocompetent cells, targeting antigens to the skin is considered to be more effective than intramuscular or subcutaneous injections. However, circumvention of the superficial layer of the skin, the stratum corneum, represents the major challenge for cutaneous immunization. An optimal delivery method has to be effective and reliable, but also highly adaptable to specific demands, should avoid the use of hypodermic needles and the requirement of specially trained healthcare workers. The P.L.E.A.S.E.® (Precise Laser Epidermal System) device employed in this study for creation of aqueous micropores in the skin fulfills these prerequisites by combining the precision of its laser scanning technology with the flexibility to vary the number, density and the depth of the micropores in a user-friendly manner. We investigated the potential of transcutaneous immunization via laser-generated micropores for induction of specific immune responses and compared the outcomes to conventional subcutaneous injection. By targeting different layers of the skin we were able to bias polarization of T cells, which could be modulated by addition of adjuvants. The P.L.E.A.S.E.® device represents a highly effective and versatile platform for transcutaneous vaccination. |
format | Online Article Text |
id | pubmed-3462999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Elsevier Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-34629992012-10-19 Transcutaneous vaccination via laser microporation Weiss, Richard Hessenberger, Michael Kitzmüller, Sophie Bach, Doris Weinberger, Esther E. Krautgartner, Wolf D. Hauser-Kronberger, Cornelia Malissen, Bernard Boehler, Christof Kalia, Yogeshvar N. Thalhamer, Josef Scheiblhofer, Sandra J Control Release Article Driven by constantly increasing knowledge about skin immunology, vaccine delivery via the cutaneous route has recently gained renewed interest. Considering its richness in immunocompetent cells, targeting antigens to the skin is considered to be more effective than intramuscular or subcutaneous injections. However, circumvention of the superficial layer of the skin, the stratum corneum, represents the major challenge for cutaneous immunization. An optimal delivery method has to be effective and reliable, but also highly adaptable to specific demands, should avoid the use of hypodermic needles and the requirement of specially trained healthcare workers. The P.L.E.A.S.E.® (Precise Laser Epidermal System) device employed in this study for creation of aqueous micropores in the skin fulfills these prerequisites by combining the precision of its laser scanning technology with the flexibility to vary the number, density and the depth of the micropores in a user-friendly manner. We investigated the potential of transcutaneous immunization via laser-generated micropores for induction of specific immune responses and compared the outcomes to conventional subcutaneous injection. By targeting different layers of the skin we were able to bias polarization of T cells, which could be modulated by addition of adjuvants. The P.L.E.A.S.E.® device represents a highly effective and versatile platform for transcutaneous vaccination. Elsevier Science Publishers 2012-09-10 /pmc/articles/PMC3462999/ /pubmed/22750193 http://dx.doi.org/10.1016/j.jconrel.2012.06.031 Text en © 2012 Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/3.0/ Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license |
spellingShingle | Article Weiss, Richard Hessenberger, Michael Kitzmüller, Sophie Bach, Doris Weinberger, Esther E. Krautgartner, Wolf D. Hauser-Kronberger, Cornelia Malissen, Bernard Boehler, Christof Kalia, Yogeshvar N. Thalhamer, Josef Scheiblhofer, Sandra Transcutaneous vaccination via laser microporation |
title | Transcutaneous vaccination via laser microporation |
title_full | Transcutaneous vaccination via laser microporation |
title_fullStr | Transcutaneous vaccination via laser microporation |
title_full_unstemmed | Transcutaneous vaccination via laser microporation |
title_short | Transcutaneous vaccination via laser microporation |
title_sort | transcutaneous vaccination via laser microporation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462999/ https://www.ncbi.nlm.nih.gov/pubmed/22750193 http://dx.doi.org/10.1016/j.jconrel.2012.06.031 |
work_keys_str_mv | AT weissrichard transcutaneousvaccinationvialasermicroporation AT hessenbergermichael transcutaneousvaccinationvialasermicroporation AT kitzmullersophie transcutaneousvaccinationvialasermicroporation AT bachdoris transcutaneousvaccinationvialasermicroporation AT weinbergeresthere transcutaneousvaccinationvialasermicroporation AT krautgartnerwolfd transcutaneousvaccinationvialasermicroporation AT hauserkronbergercornelia transcutaneousvaccinationvialasermicroporation AT malissenbernard transcutaneousvaccinationvialasermicroporation AT boehlerchristof transcutaneousvaccinationvialasermicroporation AT kaliayogeshvarn transcutaneousvaccinationvialasermicroporation AT thalhamerjosef transcutaneousvaccinationvialasermicroporation AT scheiblhofersandra transcutaneousvaccinationvialasermicroporation |